Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristen K Ciombor

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Immunotherapy in Localized Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors: Are We Ready for a New Standard of Care?Kristen K Ciombor, Cathy Eng
Journal of Surgical Oncology|March 1, 2022
Systemic therapy for gastric cancer: Perioperative strategies and beyondChristopher Cann, Kristen K Ciombor
Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Diagnosis and Management of Rectal Cancer in Patients Younger Than 50 Years: Rising Global Incidence and Unique ChallengesDaenielle Lang, Kristen K Ciombor
Pharmacogenomics and Personalized Medicine|July 22, 2014
Targeting metastatic colorectal cancer - present and emerging treatment optionsKristen K Ciombor, Jordan Berlin
Current Oncology Reports|January 22, 2014
Aflibercept--a decoy VEGF receptorKristen K Ciombor, Jordan Berlin
Current Colorectal Cancer Reports|August 24, 2016
Update on Anti-Angiogenesis Therapy in Colorectal CancerKristen K Ciombor, Richard M Goldberg
JAMA Oncology|September 30, 2016
Highlights in Gastrointestinal (Colorectal) Cancer Treatment: The Primary Tumor Sidedness Debate and Advances in ImmunotherapyKristen K Ciombor, Richard M Goldberg
The Oncologist|October 13, 2017
A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal CancerKristen K Ciombor, Tanios Bekaii-Saab
Drugs|January 20, 2018
Hypermutated Tumors and Immune Checkpoint InhibitionKristen K Ciombor, Richard M Goldberg
Hepatic Oncology|September 8, 2018
Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancerKristen K Ciombor, Richard M Goldberg
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Immunotherapy in Localized Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors: Are We Ready for a New Standard of Care?Kristen K Ciombor, Cathy Eng
Journal of Surgical Oncology|March 1, 2022
Systemic therapy for gastric cancer: Perioperative strategies and beyondChristopher Cann, Kristen K Ciombor
Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Diagnosis and Management of Rectal Cancer in Patients Younger Than 50 Years: Rising Global Incidence and Unique ChallengesDaenielle Lang, Kristen K Ciombor
Pharmacogenomics and Personalized Medicine|July 22, 2014
Targeting metastatic colorectal cancer - present and emerging treatment optionsKristen K Ciombor, Jordan Berlin
Current Oncology Reports|January 22, 2014
Aflibercept--a decoy VEGF receptorKristen K Ciombor, Jordan Berlin
Current Colorectal Cancer Reports|August 24, 2016
Update on Anti-Angiogenesis Therapy in Colorectal CancerKristen K Ciombor, Richard M Goldberg
JAMA Oncology|September 30, 2016
Highlights in Gastrointestinal (Colorectal) Cancer Treatment: The Primary Tumor Sidedness Debate and Advances in ImmunotherapyKristen K Ciombor, Richard M Goldberg
The Oncologist|October 13, 2017
A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal CancerKristen K Ciombor, Tanios Bekaii-Saab
Drugs|January 20, 2018
Hypermutated Tumors and Immune Checkpoint InhibitionKristen K Ciombor, Richard M Goldberg
Hepatic Oncology|September 8, 2018
Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancerKristen K Ciombor, Richard M Goldberg
Pageof 8